Improving sleep and cognitive function in breast cancer survivors using an app
Official title: RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention
Run by Aarhus University Hospital · NCT06553235 · Data updated 2026-11-12
This study is testing whether an app that helps with sleep can improve thinking skills in breast cancer survivors who have trouble sleeping.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 84 (estimated) |
| Sponsor | Aarhus University Hospital Academic / other |
| Locations | 1 site (Aarhus N) |
| Status | Recruiting |
| Started | December 6, 2024 |
| Main results expected | February 28, 2027 |
| Study ends | March 28, 2030 |
| Registry record updated | January 8, 2025 |
| Trial ID | NCT06553235 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are breast cancer survivors aged 18 and older who have completed treatment within the last 1-5 years and experience insomnia and cognitive impairment.
✕Probably not a fit
Patients with other sleep disorders, neurodegenerative or psychiatric conditions, or those currently pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of an app-based cognitive behavioral therapy for insomnia (CBT-I) in improving cognitive impairment among breast cancer survivors who experience insomnia. Participants will be randomly assigned to either the CBT-I intervention or an active control group receiving sleep hygiene education. The study will assess cognitive function and insomnia severity through standardized tests and follow participants for six months post-treatment. Additionally, it will explore potential changes in brain structure and inflammation related to the interventions.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life for breast cancer survivors by alleviating insomnia and improving cognitive function.
How similar studies have gone: Previous studies have shown promise in using cognitive behavioral therapy for insomnia, suggesting potential success for this app-based approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Have completed primary breast cancer (BC) treatment within 1-5 years (endocrine therapies allowed) * Insomnia: a score of \>10 on the Insomnia Severity index (ISI) and/or meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for Insomnia Disorder * Cognitive impairment: a score of "quite a bit" or "very much" on at least 1 of the 2 items measuring concentration and memory on The European Organization for Research and Treatment of Cancer Core Quality of Life (EORCT-QLQ-C30) and/or \<54 on the Cancer Therapy-Cognitive (FACT-Cog) perceived cognitive impairment (PCI) subscale Exclusion Criteria: * Other sleep disorders than insomnia that may confound sleep and/or cognitive function * Use of drugs impacting that may confound sleep and/or cognitive function (endocrine therapies allowed) * Neurodegenerative and psychiatric disorders that may confound sleep and/or cognitive function * Shift work * Pregnancy or maternity leave * Recurrence of BC or new cancer * Insufficient Danish proficiency * Substance abuse that may confound sleep and/or cognitive function * Previous experience with CBT-I * Other cancer than breast cancer
Where it's running
-
Aarhus University Hospital
Aarhus N, Denmark Recruiting
Study contacts
- Study coordinator: Ali Amidi
- Email: ali@psy.au.dk
- Phone: +4587165305
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Memantine plus structured exercise to protect thinking and memory during breast cancer chemotherapy
This will test whether memantine combined with a supervised exercise program, memantine alone, or a placebo can prevent or reduce thinking and memory problems in people receiving chemotherapy for stage I–III breast cancer.
-
Treating insomnia to improve weight loss in breast cancer survivors
This study is testing whether a sleep therapy can help overweight or obese breast cancer survivors lose weight more effectively.
-
Cognitive training and brain stimulation for women with cognitive issues after breast cancer treatment
This study is testing if a combination of brain stimulation and cognitive training can help women who have memory problems after breast cancer treatment feel better and think more clearly.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.